Public Policy Updates

Check insights and updates from APIC!

FDA/FTC Issue Warning to Sensory Cloud Inc.
04/15/2022
FDA/FTC Issue Warning to Sensory Cloud Inc.

4/8/22 — The FDA issued a warning letter jointly with the Federal Trade Commission to Sensory Cloud, Inc for selling unapproved products with unproven COVID-19 claims.

Read More
FDA Authorizes New OTC COVID Tests
04/15/2022
FDA Authorizes New OTC COVID Tests

4/8/22 — The FDA authorized two over-the-counter (OTC) at-home COVID-19 antigen tests. The validation data was gathered through the FDA’s collaboration with the National Institutes of Health (NIH) and the Independent Test Assessment Program (ITAP). The emergency use authorizations (EUA) issued to Osang LLC was for their OHC COVID-19 Antigen Self-Test and Xiamen Boson Biotech Co., Ltd for … Continued

Read More
FDA Authorizes Extended Shelf Life for Janssen Vaccine
04/15/2022
FDA Authorizes Extended Shelf Life for Janssen Vaccine

4/8/22 — The FDA authorized an extension for the shelf life of the refrigerated Janssen COVID-19 Vaccine, allowing the product to be stored at 2-8 degrees Celsius for 11 months. The vaccine was previously authorized to be stored for up to nine months. This extension was granted following a thorough review of data submitted by Janssen. … Continued

Read More
FDA Updates EUA for Sotrovimab
04/15/2022
FDA Updates EUA for Sotrovimab

4/5/22 — The FDA has again revised its EUA for sotrovimab to treat COVID-19. According to CDC data, Omicron sub-variant BA.2 now accounts for more than 50 percent of COVID-19 cases in every HHS region in the U.S.  Since the authorized dose of sotrovimab is unlikely to be effective against this sub-variant, FDA has withdrawn authorization … Continued

Read More
FDA Updates Duodenoscope Safety Recommendation
04/15/2022
FDA Updates Duodenoscope Safety Recommendation

4/5/22 — The FDA updated duodenoscope safety communication to encourage manufacturers to transition away from fixed endcap duodenoscopes to disposable/disposable component duodenoscopes with more modern design features that facilitate or eliminate the need for reprocessing. Hospitals and endoscopy facilities should complete transition to innovative duodenoscope designs that include disposable components, such as disposable endcaps, or to … Continued

Read More
Change in Reprocessing Methods with Certain Karl Storz Urological Endoscopes
04/15/2022
Change in Reprocessing Methods with Certain Karl Storz Urological Endoscopes

4/4/22 — Following FDA reports about patient infections and possible contamination issues with reprocessed urological endoscopes, Karl Storz identified reprocessing failures following high-level disinfection. The company initiated a voluntary recall and issued an urgent field safety notice to instruct users to discontinue all high-level disinfection methods for all affected urological endoscopes and discontinue liquid chemical sterilization for most … Continued

Read More
Mickey Mouse and Mandalorian Hand Sanitizer Recalled
04/15/2022
Mickey Mouse and Mandalorian Hand Sanitizer Recalled

4/4/22 — Best Brands Consumer Products is recalling two finished product lots of The Mandalorian Hand Sanitizer Ethyl Alcohol 68%, available in green and blue formulations and Mickey Mouse Hand Sanitizer Ethyl Alcohol 68% blue formulation because FDA testing found the presence of benzene in the Mandalorian Hand Sanitizer product and methanol in the Mickey Mouse … Continued

Read More
FDA Authorizes Additional Presentation for Moderna Vaccine
04/01/2022
FDA Authorizes Additional Presentation for Moderna Vaccine

3/29/22 — The FDA authorized a manufacturing change for the Moderna COVID-19 Vaccine to include an additional presentation of the vaccine for booster vaccination doses only.  The new presentation is supplied in multiple dose vials with dark blue caps and labels with a purple border. The Moderna COVID-19 Vaccine is now authorized for individuals 18 years of … Continued

Read More
FDA/FTC Warnings Against Sales of Unapproved COVID-19 Products
04/01/2022
FDA/FTC Warnings Against Sales of Unapproved COVID-19 Products

3/29/22 — The FDA issued warning letters jointly with the Federal Trade Commission to two companies for selling unapproved products with unproven COVID-19 claims. The companies that received warning letters are: Iodine Products Inc Applied Biological Laboratories Inc.

Read More